Article

Pharmacy Clinical Pearl of the Day: Breast Cancer

After skin cancer, breast cancer is the most common cancer diagnosed in women in the United States.

Clinical Pearl of the Day: Breast Cancer

Breast cancer is a cancer that forms in the cells of the breasts.

Insight:

  • After skin cancer, breast cancer is the most common cancer diagnosed in women in the United States.
  • Breast cancer can occur in both men and women, but it's far more common in women.
  • Symptoms include a breast lump or thickening that feels different; change in the size, shape, or appearance of the breast; a newly inverted nipple; peeling, scaling, crusting or flaking of the pigmented area of skin; and redness or pitting of the skin.
  • Risk factors include being female, increasing age, history of breast cancer, family history, obesity, and having a child at an older age.
  • Diagnostic tools may include breast exam, mammogram, breast ultrasound, biopsy, and MRI.
  • Treatment includes lumpectomy, mastectomy, sentinel node biopsy, axillary lymph node dissection, radiation therapy, chemotherapy, hormone therapy, targeted drug therapy, immunotherapy, and palliative care.
  • Chemotherapy can be given before surgery (neoadjuvant) or after surgery (adjuvant).
  • Adjuvant and neo-adjuvant drug may include anthracyclines, such as doxorubicin (Adriamycin), epirubicin (Ellence); taxanes such as paclitaxel (Taxol) and docetaxel (Taxotere), 5-Fluorouracil (5-FU) or capecitabine, cyclophosphamide (Cytoxan), and carboplatin.

Sources:

Related Videos
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
Image Credit: © Krakenimages.com - stock.adobe.com